RESPONSE GENETICS INC
DelistedCIK 1124608fmd_03RZQF878H4W40QY4KA6XGY73HManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jan 01, 2010 to Mar 31, 2015, 20 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|
| Total revenues | 21 | 23 | 19 | 20 | 17 |
| Cost of revenue | 10 | 12 | 10 | 10 | 0 |
| Gross profit | 11 | 11 | 8 | 9 | 7 |
| Research and development | 2 | 1 | 2 | 2 | 2 |
| Selling, general and administrative | 14 | 15 | 14 | 16 | 18 |
| Total operating expenses | – | – | 16 | 17 | 20 |
| Operating income | (5) | (6) | (8) | (8) | (13) |
| Interest expense | 0 | 0 | 0 | 0 | 1 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | 0 | – | (0) | 0 | (0) |
| Income before taxes | (5) | (6) | (8) | (8) | (14) |
| Income tax expense | 0 | – | 0 | 0 | 0 |
| Net income from continuing operations | (5) | – | (8) | (8) | (14) |
| Net income | (5) | (6) | (8) | (8) | (14) |
| Net income to common shareholders | – | – | (8) | (8) | (14) |